The role of chemotherapy in advanced thymoma

Journal of Thoracic Oncology

Volumn 5, Issue 10 SUPPL. 4, 2010, Pages

  Schmitt, Jordan ^a   Loehrer, Patrick J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anthracycline; Cisplatin; Combination chemotherapy; Single agent therapy; Thymic carcinoma; Thymoma

Indexed keywords

BEVACIZUMAB; BLEOMYCIN; CARBOPLATIN; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ERLOTINIB; ETOPOSIDE; FLUOROURACIL; GALLIUM NITRATE; GEFITINIB; IFOSFAMIDE; IMATINIB; INTERLEUKIN 2; MAYTANSINE; MESNA; OCTREOTIDE; PACLITAXEL; PEMETREXED; PREDNISONE; SURAMIN; VINCRISTINE;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARCINOMA; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; HUMAN; INFECTION; LEUKOPENIA; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; THYMOMA; TREATMENT RESPONSE;

EID: 77957557420     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181f21129     Document Type: Article

References (30)

1. Legg MA, Brady WJ. Pathology and clinical behavior of thymomas: a survey of 51 cases. Cancer 1965;18:1131-1144.
2. Batata MA, Martini N, Huvos AG, et al. Thymomas: clinicopathologic features, therapy, and prognosis. Cancer 1974;34:389-396.
3. Maggi G, Giaccone G, Donadio M, et al. Thymomas. A review of 169 cases with particular reference to results of surgical treatment. Cancer 1986;58:765-776.
4. Lewis J, Wick MR, Scheithauer BW, et al. Thymoma. A clinicopathologic review. Cancer 1987;60:2727.
5. Masaoka A, Monden Y, Nakahara K, et al. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48; 2485-2492.
6. Needles B, Kemeny N, Urmacher C. Malignant thymoma: renal metastases responding to cis-platinum. Cancer 1981;48:223-226.
7. Bonomi PD, Finkelstein D, Aisner S, et al. EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma. Am J Clin Oncol 1993;16: 342-354.
8. Highley MS, Parnis FX, Karapetis C, et al. Treatment of invasive thymoma with single-agent ifosfamide. J Clin Oncol 1999;17:2737-2744.
9. Berthaud P, LeChevalier T, Tursz T. Effective interleukin-2 in invasive lymphepithelial thymoma. Lancet 1990;335:1590 (letter).
10. Gordon MS, Battiato LA, Gonin R, et al. A phase II trial of subcutaneously administered recombinant human interleukin-2 in patients with relapsed/refractory thymoma. J Immunother Emphasis Tumor Immunol 1995;18:179-184.
11. Palmieri G, Lastoria S, Colao A, et al. Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone. N Engl J Med 1997;336:263-265.
12. Loehrer PJ, Wang W, Johnson DH, et al. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group phase II trial. J Clin Oncol 2004;22:293-299.
13. Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol 1999;17:2280-2289.
14. Tiseo M, Monetti F, Ferrarini M, et al. Dramatic responses to therapy in rare tumors. J Clin Oncol 2005;23:1578-1579.
15. Umemura S, Segawa Y, Fujiwara K, et al. A case of recurrent metastatic thymoma showing a marked response to paclitaxel monotherapy. Jpn J Clin Oncol 2002;32:262-265.
16. Hu E, Levine J. Chemotherapy of malignant thymoma: case report and review of the literature. Cancer 1986;57:1101-1104.
17. Loehrer PJ, Jiroutek M, Aisner S, et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial. Cancer 2001;91:2010-2015.
18. Loehrer PJ, Kim K, Aisner SC, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 1994;12:1164-1168.
19. Loehrer PJ, Chen M, Kim KM, et al. Cisplatin, doxorubicin and cyclophosphamide plus thoracic radiation therapy for limited stage, unresectable thymoma: an intergroup trial. J Clin Oncol 1997;15:3093-3099.
20. Kim ES, Putnam JB, Komaki R, et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 2004;44:369-379.
21. Fornasiero A, Danielle O, Ghiotto C, et al. Chemotherapy for invasive thymoma: a 13 year experience. Cancer 1991;68:30-33.
22. Giaccone GA, Ardizzoni A, Kirkpatrick A, et al. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Groups. J Clin Oncol 1996; 14:814-820.
23. Lemma GL, Loehrer PJ, Lee JW, et al. A phase II study of carboplatin plus paclitaxel in advanced thymoma or thymic carcinoma: E1C99. Proc Am Soc Clin Oncol 2008;26:8018.
24. Iwasaki Y, Ohsgi S, Takemura Y, et al. Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood stem cell transplantation for invasive thymoma. Chest 2002;122:2249-2252.
25. Gaspard MH, Maraninchi D, Stoppa AM, et al. Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies. Cancer Chemother Pharmacol 1988;22:256-262.
26. Hanna N, Gharpure VS, Abonour R, et al. High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience. Bone Marrow Transplant 2001;28:435-438.
27. Shin DM, Walsh C, Komaki R, et al. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Int Med 1998;129:101-104.
28. Berruti A, Borasto P, Roncari A, et al. Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymoma: Results in six patients. Ann Oncol 1993;4:429-431.
29. Rea F, Sartori F, Loy M, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg 1993;106:543-549.
30. Macchiarini P, Chella A, Ducci F, et al. Neoadjuvant chemotherapy, surgery and postoperative radiation therapy for invasive thymoma. Cancer 1991;68:706-713.